<?xml version="1.0" encoding="UTF-8" ?> 

<rss version="2.0"> 
<channel> 
<title>Coagulation/Bleeding Dz News</title> 
<link>http://www.mdlinx.com/HemeOncLinx/news.cfm/newspage/1/spec_id/17/subspec_id/393</link> 
<description>Coagulation/Bleeding Dz</description> 
<language>en-us</language> 
<copyright>Copyright 2009 MDLinx, Inc.</copyright>










 



<item> 
<title><![CDATA[VERITAS-Pro: a new measure of adherence to prophylactic regimens in haemophilia]]></title> 
<link>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2957629</link> 
<pubDate>11/25/2009</pubDate> 
<description><![CDATA[<b>Haemophilia</b>]]></description> 
<guid>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2957629</guid>
</item> 
 

<item> 
<title><![CDATA[Complement activation on platelets correlates with a decrease in circulating immature platelets in patients with immune thrombocytopenic purpura]]></title> 
<link>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2958238</link> 
<pubDate>11/25/2009</pubDate> 
<description><![CDATA[<b>British Journal of Haematology</b>]]></description> 
<guid>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2958238</guid>
</item> 
 

<item> 
<title><![CDATA[Src tyrosine kinase pre-activation is associated with platelet hypersensitivity in essential thrombocythemia and polycythemia vera]]></title> 
<link>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2950216</link> 
<pubDate>11/25/2009</pubDate> 
<description><![CDATA[<b>Blood</b>]]></description> 
<guid>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2950216</guid>
</item> 
 

<item> 
<title><![CDATA[The optimal mode of delivery for the haemophilia carrier expecting an affected infant is vaginal delivery]]></title> 
<link>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2956627</link> 
<pubDate>11/25/2009</pubDate> 
<description><![CDATA[<b>Haemophilia</b>]]></description> 
<guid>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2956627</guid>
</item> 
 

<item> 
<title><![CDATA[Major orthopaedic surgeries for haemophilia with inhibitors using rFVIIa]]></title> 
<link>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2956626</link> 
<pubDate>11/25/2009</pubDate> 
<description><![CDATA[<b>Haemophilia</b>]]></description> 
<guid>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2956626</guid>
</item> 


 

<item> 
<title><![CDATA[Cubital tunnel syndrome in patients with haemophilia]]></title> 
<link>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2956628</link> 
<pubDate>11/25/2009</pubDate> 
<description><![CDATA[<b>Haemophilia</b>]]></description> 
<guid>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2956628</guid>
</item> 
 

<item> 
<title><![CDATA[Force-induced cleavage of single VWF A1A2A3-tridomains by ADAMTS-13]]></title> 
<link>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2944005</link> 
<pubDate>11/25/2009</pubDate> 
<description><![CDATA[<b>Blood</b>]]></description> 
<guid>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2944005</guid>
</item> 
 

<item> 
<title><![CDATA[Rapid activation of endothelial cells enables P. falciparum adhesion to platelet decorated von Willebrand factor strings]]></title> 
<link>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2944002</link> 
<pubDate>11/25/2009</pubDate> 
<description><![CDATA[<b>Blood</b>]]></description> 
<guid>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2944002</guid>
</item> 
 

<item> 
<title><![CDATA[Combination immunosuppressant therapy for patients with chronic refractory immune thrombocytopenic purpura]]></title> 
<link>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2943999</link> 
<pubDate>11/25/2009</pubDate> 
<description><![CDATA[<b>Blood</b>]]></description> 
<guid>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2943999</guid>
</item> 
 
 


  


</channel> 
</rss>

